Yossef Av-Gay, PhD

avgayweb1

Professor
Division of Infectious Diseases

Associate Member
Department of Microbiology and Immunology, UBC

phone: 604-875-4329
lab: 604-875-4111 x63914
fax:604-875-4013

yossi(at)interchange.ubc.ca

www.id.med.ubc.ca/Faculty/Yossi.htm


Molecular Genetics of Mycobacteria

Tuberculosis (TB) is the leading killer of adults by infectious diseases, and poses a serious challenge to international public health. So great is the concern regarding the magnitude of the modern TB epidemic that in April 1993 the World Health Organization (WHO) declared TB to be a "global emergency"; the first declaration of its kind in WHO history. Until recently, TB was considered to be a minor and decreasing problem in industrialized countries, even though M.tuberculosis is still the leading bacterial cause of human mortality in the world. More than 10 million new cases of TB arise annually, causing more than 3 million deaths each year. The steady decline of TB in industrialized countries has also recently undergone a dramatic reversal. Multidrug resistant strains of M.tuberculosis are spreading from patients to the general population. The explosive re-emergence of TB together with recent development of recombinant DNA technology in mycobacteria, has brought mycobacterial research, neglected over the past 20 years, to the forefront of microbiological research.

Dr. Av-Gay's Laboratory research is focused on the molecular pathogenesis of Mycobacterium tuberculosis in order to identify new targets for drug therapy. Using bioinformatic and pathogenomic tools, we have identified three molecular targets and we are now characterizing them for their contribution to TB pathogenesis. These targets are protein kinases of M. tuberculosis, mycothiol production and cholesterol utilization by mycobacteria.

 

Education

PhD - Microbial Genetics - Tel Aviv University

MSc - Microbiology - Tel Aviv University

BSc - Biology - Tel Aviv University

 

Recent Publications

Vilcheze, C., Av-Gay, Y. Attarian R, Liu Z, Hazbón MH, Colangeli R, Chen B, Liu W, Alland D, Sacchettini JC, Jacobs Jr WR. (2008). Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Molecular Microbiology. In Press.

Bach, H. Papavinasasundaram, K. G., Wong , D., Hmama, Z., and Av-Gay, Y. (2008) Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of Human VPS33B. Cell Host &Microbe. 3(5):316-22.

Miller,C. C. Rawat, M., Johnson, T., and Av-Gay, Y. (2007). Innate Protection of Mycobacteria Against the Antimicrobial Activity of Nitric Oxide is Provided by Mycothiol. Anti Microbial Agents and Chemotherapy, 51(9):3364-3366.

Gopalasawamy, R., Naryanan, S., Jacobs. W.R., Jr., Ko, M., and Av-Gay, Y. (2008). Protein kinase MSMEG3682 from M. smegmatis is essential for maintenance of cell wall architecture and cell division. FEMS Microbiology Letters. 278:121-127.

Mamta Rawat and and Yosef Av-Gay. (2007). Mycothiol dependent Proteins in Actinomycetes. FEMS Microbiology Reviews. 31:278-292.

Zheng, X., Papavinasasundaram, K.G., and Av-Gay, Y. (2007). Novel Substrates of Mycobacterium tuberculosis PknH serine / Threonine Kinase. BBRC. 355:162-168.

Deghmane AE, Soualhine H,Bach, H., Sendide K, Itoh S, Tam A, Noubir S, Talal A, Lo R, Toyoshima S, Av-Gay Y, Hmama Z. (2007). LpdC mediates retention of coronin-1 on M. bovis BCG vacuoles, leading to arrest in phagosome maturation. J. Cell Sci 120 (16):2796-2806

Rawat, M., Johnson, T., Cadiz, V., and Av-Gay Y. (2007). Comparative analysis of mutants in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. BBRC. 363:71-76.

Bach, H., Sun, J., Wong , D., Hmama, Z. and Av-Gay Y. (2006), Mycobacterium avium ssp paratuberculosis PtpA is an endogenous tyrosine phosphatase secreted during infection. Infection and Immunity. 4:6540-6546.

Newton, G. L., Koledin, T., Ko, M., Av-Gay, Y., and Fahey, R.C. (2006). N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-D-glucopyranoside Deacetylase, a Mycothiol Biosynthetic Enzyme (MshB), is a metalloprotein subject to feedback inhibition by Mycothiol. Protein Expression and Purification. 47:542-550.

Pick, N., Rawat, M., Arad, D., Lan, J., Fan, J., Kende, A.S., and Av-Gay, Y. (2006). In Vitro Properties of Antimicrobial Bromo-Tyrosine Alkaloids. J. Med. Microbiol. 55: 407-415.

Ung S.E.K,, and Av-Gay, Y. (2006). Mycothiol Dependent Mycobacterial Response to Oxidative Stress. FEBS Letters. 580:2712-2716.

Pérez, J., Garcia, R. L., Bach, H., H de Waard, J., Jacobs, W. R. Jr., Av-Gay, Y., Bubis, J and Takiff H. (2006). Mycobacterium tuberculosis transporter MmpL7 is a potential substrate for kinase PknD. BBRC. 348:6-12.

Papavinasasundaram KG., Chan B., Chung JH., Colston MJ., Davis EO., Av-Gay Y. (2005). Deletion of the Mycobacterium tuberculosis pknH Gene Confers a Higher Bacillary Load during the Chronic Phase of Infection in BALB/c Mice. J Bacteriol. 187(16):5751-60.
PDF

Dosanjh NS., Rawat M., Chung JH., Av-Gay Y. (2005). Thiol specific oxidative stress response in Mycobacteria. FEMS Microbiol PMID: 16006064.
PDF

Hestvik AL., Hmama Z., Av-Gay Y. (2005). Mycobacterial manipulation of the host cell. FEMS Microbiol PMID: 16040149.
PDF

Pick N., Cameron S., Arad D., Av-Gay Y. (2004). Screening of Compounds Toxicity against Human Monocytic cell line-THP-1 by Flow Cytometry. Biol Proced Online. 6:220-225.
PDF

Rawat M., Uppal M., Newton G., Steffek M., Fahey RC., Av-Gay Y. (2004). Targeted mutagenesis of the Mycobacterium smegmatis mca gene, encoding a mycothiol-dependent detoxification protein. J Bacteriol. 186(18):6050-8.
PDF

Cowley S., Ko M., Pick N., Chow R., Downing KJ., Gordhan BG., Betts JC., Mizrahi V., Smith DA., Stokes RW., Av-Gay Y. (2004). The Mycobacterium tuberculosis protein serine/threonine kinase PknG is linked to cellular glutamate/glutamine levels and is important for growth in vivo. Mol Microbiol. 52(6):1691-702.
PDF

Wiens T., Redelmeier T., Av-Gay Y. (2004). Development of a liposome formulation of ethambutol. Antimicrob Agents Chemother. 48(5):1887-8.
PDF